iShares U.S. Pharmaceuticals ETF (IHE) Research
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Market snapshot
- Symbol
- IHE
- Price
- $91.88
- Day change
- -1.02%
- Market cap
- $712.4M
- 52-week range
- 64.46-95.6
- Sector
- Financial Services
- Industry
- Asset Management
Recent news
- Trump to announce discount drug pricing expansion, White House official says
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Monday, a White House official said.
- Could pressure to make money faster kill the next lifesaving pill?
When activist investors take a stake in a pharmaceutical company, markets often cheer. The expectation is leaner operations, sharper strategy and higher stock prices.
Peer companies
- BNY Mellon US Mid Cap Core Equity ETF (BKMC)
- WisdomTree International Equity Fund (DWM)
- iShares North American Natural Resources ETF (IGE)
- iShares India 50 ETF (INDY)
- iShares U.S. Basic Materials ETF (IYM)
- iShares U.S. Telecommunications ETF (IYZ)
- iShares MSCI Saudi Arabia ETF (KSA)
- VanEck Pharmaceutical ETF (PPH)
Open iShares U.S. Pharmaceuticals ETF (IHE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.